APO RESEARCH · REPORT
Hemostatic and Tissue Sealing Agents
Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.
Product & engineering
Understand the product.
Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.
Selected research
Industry Research
Hemostatic and Tissue Sealing Agents Industry Research Report 2026
Market perspective
Hemostasis is defined as "the blocking of bleeding or bleeding through blood vessels or other parts of the body".Hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually lead to surgery for patients, which in turn promotes the development of the hemostasis and tissue sealant industries.
Global Hemostatic and Tissue Sealing Agents key players include J&J, Baxter, C R Bard, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share about 60%, followed by China, and Europe, both have a share about 30 percent.
Read the full market overview
In terms of product, Hemostatic is the largest segment, with a share about 75%. And in terms of application, the largest application is General Surgery, followed by Minimally Invasive Surgery, etc.
Report Scope
This report quantifies the global Hemostatic and Tissue Sealing Agents market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hemostatic and Tissue Sealing Agents Market by Company
J&J
Baxter
C R Bard
B Braun
Integra Life Sciences
Advance Medical Solution
CSL Behring
CryoLife
Zimmer Biomet
Pfizer
Medtronic
Smith & Nephew
Cohera Medical
Shanghai Haohai Biological Technology Co. Ltd.
Shandong Saikesaisi Biotechnology Co., Ltd
Chang ShaHai Run biological technology Co, LTD
Hemostatic and Tissue Sealing Agents Segment by Type
Hemostatic
Sealant Gum
Hemostatic and Tissue Sealing Agents Segment by Application
Minimally Invasive Surgery
General Surgery
Other
Hemostatic and Tissue Sealing Agents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic and Tissue Sealing Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemostatic and Tissue Sealing Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic and Tissue Sealing Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hemostatic and Tissue Sealing Agents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hemostatic and Tissue Sealing Agents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hemostatic and Tissue Sealing Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hemostatic
- Sealant Gum
Applications
- Minimally Invasive Surgery
- General Surgery
- Other
Companies covered
- J&J
- Baxter
- C R Bard
- B Braun
- Integra Life Sciences
- Advance Medical Solution
- CSL Behring
- CryoLife
- Zimmer Biomet
- Pfizer
- Medtronic
- Smith & Nephew
- Cohera Medical
- Shanghai Haohai Biological Technology Co. Ltd.
- Shandong Saikesaisi Biotechnology Co., Ltd
- Chang ShaHai Run biological technology Co, LTD
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hemostatic and Tissue Sealing Agents Market Size (2021-2032)
- 2.2.2 Global Hemostatic and Tissue Sealing Agents Sales (2021-2032)
- 2.2.3 Global Hemostatic and Tissue Sealing Agents Market Average Price (2021-2032)
- 2.3 Hemostatic and Tissue Sealing Agents by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Hemostatic
- 2.3.3 Sealant Gum
- 2.4 Hemostatic and Tissue Sealing Agents by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Minimally Invasive Surgery
- 2.4.3 General Surgery
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hemostatic and Tissue Sealing Agents Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hemostatic and Tissue Sealing Agents Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Hemostatic and Tissue Sealing Agents Revenue of Manufacturers (2021-2026)
- 3.4 Global Hemostatic and Tissue Sealing Agents Average Price by Manufacturers (2021-2026)
- 3.5 Global Hemostatic and Tissue Sealing Agents Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hemostatic and Tissue Sealing Agents, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hemostatic and Tissue Sealing Agents, Product Type & Application
- 3.8 Global Manufacturers of Hemostatic and Tissue Sealing Agents, Established Date
- 3.9 Global Hemostatic and Tissue Sealing Agents Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 J&J
- 4.1.1 J&J Company Information
- 4.1.2 J&J Business Overview
- 4.1.3 J&J Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 J&J Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.1.5 J&J Recent Developments
- 4.2 Baxter
- 4.2.1 Baxter Company Information
- 4.2.2 Baxter Business Overview
- 4.2.3 Baxter Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Baxter Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.2.5 Baxter Recent Developments
- 4.3 C R Bard
- 4.3.1 C R Bard Company Information
- 4.3.2 C R Bard Business Overview
- 4.3.3 C R Bard Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 C R Bard Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.3.5 C R Bard Recent Developments
- 4.4 B Braun
- 4.4.1 B Braun Company Information
- 4.4.2 B Braun Business Overview
- 4.4.3 B Braun Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 B Braun Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.4.5 B Braun Recent Developments
- 4.5 Integra Life Sciences
- 4.5.1 Integra Life Sciences Company Information
- 4.5.2 Integra Life Sciences Business Overview
- 4.5.3 Integra Life Sciences Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Integra Life Sciences Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.5.5 Integra Life Sciences Recent Developments
- 4.6 Advance Medical Solution
- 4.6.1 Advance Medical Solution Company Information
- 4.6.2 Advance Medical Solution Business Overview
- 4.6.3 Advance Medical Solution Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Advance Medical Solution Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.6.5 Advance Medical Solution Recent Developments
- 4.7 CSL Behring
- 4.7.1 CSL Behring Company Information
- 4.7.2 CSL Behring Business Overview
- 4.7.3 CSL Behring Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 CSL Behring Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.7.5 CSL Behring Recent Developments
- 4.8 CryoLife
- 4.8.1 CryoLife Company Information
- 4.8.2 CryoLife Business Overview
- 4.8.3 CryoLife Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 CryoLife Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.8.5 CryoLife Recent Developments
- 4.9 Zimmer Biomet
- 4.9.1 Zimmer Biomet Company Information
- 4.9.2 Zimmer Biomet Business Overview
- 4.9.3 Zimmer Biomet Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Zimmer Biomet Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.9.5 Zimmer Biomet Recent Developments
- 4.10 Pfizer
- 4.10.1 Pfizer Company Information
- 4.10.2 Pfizer Business Overview
- 4.10.3 Pfizer Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pfizer Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.10.5 Pfizer Recent Developments
- 4.11 Medtronic
- 4.11.1 Medtronic Company Information
- 4.11.2 Medtronic Business Overview
- 4.11.3 Medtronic Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Medtronic Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.11.5 Medtronic Recent Developments
- 4.12 Smith & Nephew
- 4.12.1 Smith & Nephew Company Information
- 4.12.2 Smith & Nephew Business Overview
- 4.12.3 Smith & Nephew Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Smith & Nephew Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.12.5 Smith & Nephew Recent Developments
- 4.13 Cohera Medical
- 4.13.1 Cohera Medical Company Information
- 4.13.2 Cohera Medical Business Overview
- 4.13.3 Cohera Medical Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Cohera Medical Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.13.5 Cohera Medical Recent Developments
- 4.14 Shanghai Haohai Biological Technology Co. Ltd.
- 4.14.1 Shanghai Haohai Biological Technology Co. Ltd. Company Information
- 4.14.2 Shanghai Haohai Biological Technology Co. Ltd. Business Overview
- 4.14.3 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Shanghai Haohai Biological Technology Co. Ltd. Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.14.5 Shanghai Haohai Biological Technology Co. Ltd. Recent Developments
- 4.15 Shandong Saikesaisi Biotechnology Co., Ltd
- 4.15.1 Shandong Saikesaisi Biotechnology Co., Ltd Company Information
- 4.15.2 Shandong Saikesaisi Biotechnology Co., Ltd Business Overview
- 4.15.3 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Shandong Saikesaisi Biotechnology Co., Ltd Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.15.5 Shandong Saikesaisi Biotechnology Co., Ltd Recent Developments
- 4.16 Chang ShaHai Run biological technology Co, LTD
- 4.16.1 Chang ShaHai Run biological technology Co, LTD Company Information
- 4.16.2 Chang ShaHai Run biological technology Co, LTD Business Overview
- 4.16.3 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Chang ShaHai Run biological technology Co, LTD Hemostatic and Tissue Sealing Agents Product Portfolio
- 4.16.5 Chang ShaHai Run biological technology Co, LTD Recent Developments
5 Global Hemostatic and Tissue Sealing Agents Market Scenario by Region
- 5.1 Global Hemostatic and Tissue Sealing Agents Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hemostatic and Tissue Sealing Agents Sales by Region: 2021-2032
- 5.2.1 Global Hemostatic and Tissue Sealing Agents Sales by Region: 2021-2026
- 5.2.2 Global Hemostatic and Tissue Sealing Agents Sales by Region: 2027-2032
- 5.3 Global Hemostatic and Tissue Sealing Agents Revenue by Region: 2021-2032
- 5.3.1 Global Hemostatic and Tissue Sealing Agents Revenue by Region: 2021-2026
- 5.3.2 Global Hemostatic and Tissue Sealing Agents Revenue by Region: 2027-2032
- 5.4 North America Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
- 5.4.1 North America Hemostatic and Tissue Sealing Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hemostatic and Tissue Sealing Agents Sales by Country (2021-2032)
- 5.4.3 North America Hemostatic and Tissue Sealing Agents Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
- 5.5.1 Europe Hemostatic and Tissue Sealing Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hemostatic and Tissue Sealing Agents Sales by Country (2021-2032)
- 5.5.3 Europe Hemostatic and Tissue Sealing Agents Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hemostatic and Tissue Sealing Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hemostatic and Tissue Sealing Agents Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hemostatic and Tissue Sealing Agents Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
- 5.7.1 South America Hemostatic and Tissue Sealing Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hemostatic and Tissue Sealing Agents Sales by Country (2021-2032)
- 5.7.3 South America Hemostatic and Tissue Sealing Agents Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hemostatic and Tissue Sealing Agents Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hemostatic and Tissue Sealing Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hemostatic and Tissue Sealing Agents Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hemostatic and Tissue Sealing Agents Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hemostatic and Tissue Sealing Agents Sales by Type (2021-2032)
- 6.1.1 Global Hemostatic and Tissue Sealing Agents Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Type (2021-2032)
- 6.2 Global Hemostatic and Tissue Sealing Agents Revenue by Type (2021-2032)
- 6.2.1 Global Hemostatic and Tissue Sealing Agents Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Type (2021-2032)
- 6.3 Global Hemostatic and Tissue Sealing Agents Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hemostatic and Tissue Sealing Agents Sales by Application (2021-2032)
- 7.1.1 Global Hemostatic and Tissue Sealing Agents Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Hemostatic and Tissue Sealing Agents Sales Market Share by Application (2021-2032)
- 7.2 Global Hemostatic and Tissue Sealing Agents Revenue by Application (2021-2032)
- 7.2.1 Global Hemostatic and Tissue Sealing Agents Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hemostatic and Tissue Sealing Agents Revenue Market Share by Application (2021-2032)
- 7.3 Global Hemostatic and Tissue Sealing Agents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hemostatic and Tissue Sealing Agents Value Chain Analysis
- 8.1.1 Hemostatic and Tissue Sealing Agents Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hemostatic and Tissue Sealing Agents Production Mode & Process
- 8.2 Hemostatic and Tissue Sealing Agents Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hemostatic and Tissue Sealing Agents Distributors
- 8.2.3 Hemostatic and Tissue Sealing Agents Customers
9 Global Hemostatic and Tissue Sealing Agents Analyzing Market Dynamics
- 9.1 Hemostatic and Tissue Sealing Agents Industry Trends
- 9.2 Hemostatic and Tissue Sealing Agents Industry Drivers
- 9.3 Hemostatic and Tissue Sealing Agents Industry Opportunities and Challenges
- 9.4 Hemostatic and Tissue Sealing Agents Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst